K010337

Substantially Equivalent

LIPOPRINT SYSTEM, LDL SUBFRACTIONS

Applicant: Quantimetrix Corp.
Product code: JHO
Advisory panel: Clinical Chemistry
Date received: 2001-02-05
Decision date: 2001-07-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Redondo Beach, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.